Checking drug interactions of a new medicine in healthy adults
Treatments studied
This study checks if a new oral drug, MDR-001, interacts safely with two common medicines (rifampin and itraconazole) when taken together. It's for healthy volunteers, and the results will help guide dosing for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 55 years old.
- Your weight must be at least 110 pounds (50 kg) for men, and about 99 pounds (45 kg) for women.
- Your body mass index (BMI) must be between 18 and 28.
- You cannot smoke more than 5 cigarettes a day.
- You cannot have a history of headaches like migraines.
- You must not be taking any medications, vitamins, or herbal supplements for at least 2 weeks before the study starts.
- If you are female, you cannot be pregnant or breastfeeding.
- You must agree to use effective birth control (like condoms) from 2 weeks before screening until 6 months after the study ends.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (MDR-001) in people with mild to moderate liver problems to see how the body processes it and if it's safe. It may help doctors find the right dose for patients with liver disease.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.
This trial tests a new drug called HS-10504 in healthy adults to see how the body processes it. It is an early-phase study that helps determine safe dosing.
This study checks how your body handles a new medicine when it is taken with rifampicin, a common antibiotic. It helps researchers understand if the new medicine is safe and how it interacts with other drugs.
This study checks how the body processes two medications when taken together: rifampin (an antibiotic) and anaprazole sodium (a stomach acid reducer). It is not a treatment trial — it is for healthy volunteers to see if these drugs interact in a way that could affect dosing.
Hear when a new Healthy Volunteers (HV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.